En klass läkemedel, vars användning är inriktad på behandling av högt blodtryck och hjärtsvikt. Deras hemodynamiska effekt ligger i att de hämmar renin-angiotensinsystemet. De modulerar också det symp atiska nervsystemets aktivitet och ökar prostaglandinsyntesen. Den huvudsakliga verkan är kärlvidgande och svagt natriuretisk.
A class of drugs whose main indications are the treatment of hypertension and heart failure. They exert their hemodynamic effect mainly by inhibiting the renin-angiotensin system. They also modulate sympathetic nervous system activity and increase prostaglandin synthesis. They cause mainly vasodilation and mild natriuresis without affecting heart rate and contractility.
ACE-inhibitorer — ACE-hämmare
Angiotensin Converting Enzyme Inhibitors — Enzyme Inhibitors, Angiotensin-Converting — Inhibitors, Angiotensin-Converting Enzyme — Inhibitors, Angiotensin Converting Enzyme — Inhibitors, Kininase II — Kininase II Antagonists — Kininase II Inhibitors — Angiotensin-Converting Enzyme Antagonists — Angiotensin Converting Enzyme Antagonists — Enzyme Antagonists, Angiotensin-Converting — Kininase II Inhibitor — II Inhibitor, Kininase — Inhibitor, Kininase II — Antagonists, Kininase II — Inhibitors, ACE — ACE Inhibitors — Angiotensin I-Converting Enzyme Inhibitors — Angiotensin I Converting Enzyme Inhibitors — Angiotensin Converting Enzyme Inhibitor — ACE Inhibitor — Inhibitor, ACE — Angiotensin I-Converting Enzyme Inhibitor — Angiotensin I Converting Enzyme Inhibitor — Angiotensin-Converting Enzyme Inhibitor — Enzyme Inhibitor, Angiotensin-Converting — Inhibitor, Angiotensin-Converting Enzyme — Antagonists, Angiotensin-Converting Enzyme — Antagonists, Angiotensin Converting Enzyme